Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Backer Marianne De

CEO at Vir Biotechnology, Inc. (VIR); CEO, President at Vir Biotechnology, Inc. (VIR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $947K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 7SEC VIRVir Biotechnology, Inc. Sell Plan 72,559948,145 held (−7%) $9.16 $665K +8.7%
Feb 26SEC VIRVir Biotechnology, Inc. Sell Plan 14,7621,020,704 held (−1%) $9.53 $141K +4.5%
Feb 24SEC VIRVir Biotechnology, Inc. Sell Plan 19,0391,035,466 held (−2%) $7.45 $142K +33.7%
  • Sell

    CEO, President Backer Marianne De sold $665K of VIR at $9.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Backer Marianne De sold $141K of VIR at $9.53 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Backer Marianne De sold $142K of VIR at $7.45 — pre-scheduled 10b5-1 plan sale.